Table 4.

Clinical characteristics of 42 PS-matched pairs of patients in the mPSL+PSL and PSL groups

Patient CharacteristicsInitial Use of CorticosteroidP Value
mPSL+PSLPSL
Number4242
Baseline characteristics at initiation of corticosteroid
 Age, yr45 [28−62]41 [21−67]0.94
 Men, n (%)27 (64.3)28 (66.7)0.83
 Body mass index, kg/m222.9±2.823.0±3.10.91
 Systolic BP, mmHg119±13121±160.69
 Diastolic BP, mmHg72±1171±110.70
 Use of antihypertensives, n (%)8 (19.0)8 (19.0)1.00
 Creatinine, mg/dl0.9 [0.8−1.2]0.9 [0.7−1.3]0.96
 Total cholesterol, mg/dl370±103391±1110.38
 Albumin, g/dl1.9±0.51.9±0.60.91
 Urinary protein, g/d7.4 [4.2−15.3]10.3 [4.0−15.6]0.86
 Use of intravenous 25% albumin, n (%)22 (52.4)24 (57.1)0.56
 Initial PSL dose, mg/kg0.75±0.130.69±0.150.08
First remission and relapse
 First remission, n (%)42 (100.0)41 (97.6)
 Time to first remission, da12 [7−24]18 [12−25]
 First relapse, n (%)a22 (52.4)31 (75.6)
 Time to first relapse, yrb1.3 [0.8−1.7]0.8 [0.4−1.2]
  • Values are given as mean±SD, median [interquartile range], or median (range). Conversion factors for units: serum creatinine in milligrams per deciliter to moles per liter, ×88.4; serum total cholesterol in milligrams per deciliter to moles per liter, ×0.02586.

  • a Excluding one patient who was censored without remission after receiving immunosuppressive therapy.

  • b Excluding 31 patients who were censored without relapse after receiving immunosuppressive therapy.